A melanogenesis inhibitor combination is provided, comprising: a combination of (Z)—；N-(4-hydroxybenzylidene)propan-2-amine oxide； and a compound of formula Iwherein R1 and R2 are independently selected from a hydrogen atom and an acyl group having 3 to 20 carbon atoms； wherein the combination is dispersed in a dermatologically acceptable carrier.
